 This study found that high doses of dexamethane can reduce the risk of developing diuretic fluid retention during breast cancer treatment. The researchers observed that the incidence of diuretic fluid retention was significantly reduced when patients received higher doses of dexamethane. They also noted that the maximum variation of body weight was significantly lower in the group who received higher doses of dexamethane. This article was authored by Yoshitokasaito, Ryotakano, Yotukikuma, and others.